Alzheimer'S Disease Clinical Trials in High Point, NC

Alzheimer'S Disease Clinical Trials in High Point, NC

View the best 10 alzheimer's disease medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Alzheimer'S Disease clinical trial.

Trials in High Point, North Carolina

Here are the top 10 medical studies for alzheimer's disease in High Point, North Carolina

Image of Location - 001 in Princeton, United States.

KarXT

Behavioural Intervention

Recruiting1 awardPhase 3
This trial aims to test the safety and effectiveness of KarXT in adults with Alzheimer's Disease who also have psychosis.
Image of Kingfisher Cooperative in Spokane, United States.

AR1001

Recruiting1 awardPhase 3
This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.
Image of Atrium Health Wake Forest Baptist in Winston-Salem, United States.

Histidine Oral Supplementation

Behavioural Intervention

Recruiting2 awardsPhase 4
This trial seeks to improve cognition by increasing brain Histidine, Anserine & Carnosine via oral Histidine supplementation in patients with cognitive dysfunction.
Image of Sanders-Brown Center on Aging in Lexington, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial will test whether a new drug can help treat early Alzheimer's.
Image of University of North Carolina, Chapel Hill in Chapel Hill, United States.

Primary Care Team Advance Care Planning With People with Alzheimer's Disease or a Related Dementia Training

Behavioral Intervention

Recruiting1 award1 criteria
This trial will test a toolkit called Dementia Advance Care Planning (AD ACP) to see if it helps people with dementia and their primary care team members have better discussions about their care preferences. The
Image of University of South Florida in Tampa, United States.

Cognitive Training +1 More

Behavioural Intervention

Recruiting2 awardsPhase 3
This trial will test if a cognitive training technique can help delay the onset of mild cognitive impairment or dementia.
Image of Duke University Medical Center in Durham, United States.

Network-guided TMS

Neuromodulation

Recruiting1 award6 criteria
This trial uses magnetic stimulation to target brain areas identified through MRI scans. It focuses on adults with mild cognitive impairment, aiming to improve memory by enhancing brain connectivity and function. Repetitive transcranial magnetic stimulation (rTMS) has been shown to improve cognitive function in patients with mild cognitive impairment (MCI).
Image of PRIM: CenExel - CNS in Los Alamitos, United States.

LY4006895

Monoclonal Antibodies

Recruiting0 awardsPhase 1
This trial aims to test the safety and tolerance of a new drug called LY4006895. Part A will give a single dose to healthy people, while Part B will give multiple doses to those with
Image of Local Institution - 0001 in Tampa, United States.

BMS-986368

FAAH/MGLL inhibitor

Recruiting0 awardsPhase 2
This trial is testing a new drug called BMS-986368 to see if it is effective, safe, and well-tolerated in treating agitation in people with Alzheimer's Disease.
Image of Banner Alzheimer's Institute- Clinical Trials Department in Phoenix, United States.

ACU193

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial aims to test if ACU193 infusions given every four weeks can help slow down mental and physical decline in people with early Alzheimer's disease compared to a placebo.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.